HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development.

Abstract
Esophageal squamous cell carcinoma (ESCC) is a highly malignant tumor which usually is diagnosed in advanced stages due to its asymptomatic course of tumorigenesis. Current therapeutic modalities are not effective enough and the 5-year survival rate of the disease is still very low which prompts the urgent need for finding novel efficient therapeutic methods. In this study, we evaluated ex vivo immune response of ESCC patients against our newly designed chimeric construct consisting of highly immunogenic cancer-testis antigens. After confirming effective expression of the in vitro transcribed chimeric mRNA in ex vivo electroporated dendritic cells (DCs) of the ESCC patients, the patients' CTLs were primed by DCs and cytotoxicity assay was performed to evaluate how the primed CTLs can recognize and target the chimeric mRNA-loaded cells. The chimeric protein was strongly expressed relative to the housekeeping gene expression in electroporated cells. The cytotoxicity of the CTLs was significantly higher in DCs loaded with chimeric mRNAs compared to mock DCs (p<0.05) in all of the tested ESCC patients. We are introducing a novel construct that our functional study showed can stimulate and induce an effective immune response in ESCC patients. The designed chimeric mRNA-loaded DCs are capable of priming CTLs effectively and induce cytotoxicity against tumor. Therefore, loading DCs with chimeric epitopes of highly immunogenic antigens, such as cancer-testis antigens, are potentially interesting and effective therapeutic modalities for immunotherapy of ESCC.
AuthorsMohammad Mahdi Forghanifard, Mehran Gholamin, Omeed Moaven, Moein Farshchian, Martha Ghahraman, Amir Aledavood, Mohammad Reza Abbaszadegan
JournalMedical oncology (Northwood, London, England) (Med Oncol) Vol. 31 Issue 10 Pg. 191 (Oct 2014) ISSN: 1559-131X [Electronic] United States
PMID25178937 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Cancer Vaccines
Topics
  • Adult
  • Antigens, Neoplasm (immunology)
  • Blotting, Western
  • Cancer Vaccines (immunology)
  • Carcinoma, Squamous Cell (immunology)
  • Cell Line, Tumor
  • Cloning, Organism
  • Cytotoxicity, Immunologic
  • Dendritic Cells (immunology)
  • Electrophoresis, Polyacrylamide Gel
  • Electroporation
  • Esophageal Neoplasms (immunology)
  • Esophageal Squamous Cell Carcinoma
  • Flow Cytometry
  • Humans
  • Immunotherapy
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: